184 related articles for article (PubMed ID: 11567943)
21. Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
Bassal M; La MK; Whitlock JA; Sather HN; Heerema NA; Gaynon PS; Stork LC
Pediatr Blood Cancer; 2005 Jan; 44(1):21-8. PubMed ID: 15368546
[TBL] [Abstract][Full Text] [Related]
22. Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000).
Goubin A; Auclerc MF; Auvrignon A; Patte C; Bergeron C; Hémon D; Clavel J
Eur J Cancer; 2006 Mar; 42(4):534-41. PubMed ID: 16412629
[TBL] [Abstract][Full Text] [Related]
23. Remission death in acute lymphoblastic leukaemia: a changing pattern.
Atra A; Richards SM; Chessells JM
Arch Dis Child; 1993 Nov; 69(5):550-4. PubMed ID: 8257173
[TBL] [Abstract][Full Text] [Related]
24. Treatment outcomes in children with Acute lymphoblastic leukemia with versus without coexisting Down's syndrome: A systematic review and meta-analysis.
Liao W; Liu Y
Medicine (Baltimore); 2020 Jul; 99(29):e21015. PubMed ID: 32702842
[TBL] [Abstract][Full Text] [Related]
25. Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.
Athale UH; Puligandla M; Stevenson KE; Asselin B; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Sulis ML; Welch JJG; Harris MH; Neuberg DS; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2018 Oct; 65(10):e27256. PubMed ID: 29878490
[TBL] [Abstract][Full Text] [Related]
26. Clinical and biological characteristics of acute lymphocytic leukemia in children with Down syndrome.
Kalwinsky DK; Raimondi SC; Bunin NJ; Fairclough D; Pui CH; Relling MV; Ribeiro R; Rivera GK
Am J Med Genet Suppl; 1990; 7():267-71. PubMed ID: 2149960
[TBL] [Abstract][Full Text] [Related]
27. Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol.
Patrick K; Wade R; Goulden N; Rowntree C; Hough R; Moorman AV; Mitchell CD; Vora A
Br J Haematol; 2014 May; 165(4):552-5. PubMed ID: 24428704
[TBL] [Abstract][Full Text] [Related]
28. Improved outcome of acute myeloid leukaemia in Down's syndrome.
Craze JL; Harrison G; Wheatley K; Hann IM; Chessells JM
Arch Dis Child; 1999 Jul; 81(1):32-7. PubMed ID: 10373130
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.
Forestier E; Izraeli S; Beverloo B; Haas O; Pession A; Michalová K; Stark B; Harrison CJ; Teigler-Schlegel A; Johansson B
Blood; 2008 Feb; 111(3):1575-83. PubMed ID: 17971484
[TBL] [Abstract][Full Text] [Related]
30. Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994.
Stiller CA; Eatock EM
Arch Dis Child; 1999 Sep; 81(3):202-8. PubMed ID: 10451391
[TBL] [Abstract][Full Text] [Related]
31. Leukaemia survival trends in children with Down's syndrome in Great Britain, 1971-2000: a population-based study.
Shah A; Stiller C; Lancaster D; Vincent T; Coleman MP
J Epidemiol Community Health; 2010 Jul; 64(7):604-9. PubMed ID: 19703908
[TBL] [Abstract][Full Text] [Related]
32. How I treat ALL in Down's syndrome: pathobiology and management.
Izraeli S; Vora A; Zwaan CM; Whitlock J
Blood; 2014 Jan; 123(1):35-40. PubMed ID: 24235135
[TBL] [Abstract][Full Text] [Related]
33. Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries.
Lundin C; Forestier E; Klarskov Andersen M; Autio K; Barbany G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Johansson B; ; ;
J Hematol Oncol; 2014 Apr; 7():32. PubMed ID: 24726034
[TBL] [Abstract][Full Text] [Related]
34. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis.
Fong CT; Brodeur GM
Cancer Genet Cytogenet; 1987 Sep; 28(1):55-76. PubMed ID: 2955886
[TBL] [Abstract][Full Text] [Related]
35. Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia.
Bohnstedt C; Levinsen M; Rosthøj S; Zeller B; Taskinen M; Hafsteinsdottir S; Björgvinsdóttir H; Heyman M; Schmiegelow K;
Leukemia; 2013 Apr; 27(4):866-70. PubMed ID: 23138181
[TBL] [Abstract][Full Text] [Related]
36. Child and adolescent Down syndrome-associated leukaemia: the Irish experience.
O'Rafferty C; Kelly J; Storey L; Ryan C; O'Marcaigh A; Smith O
Ir J Med Sci; 2015 Dec; 184(4):877-82. PubMed ID: 25344131
[TBL] [Abstract][Full Text] [Related]
37. Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States.
Salazar EG; Li Y; Fisher BT; Rheingold SR; Fitzgerald J; Seif AE; Huang YS; Bagatell R; Aplenc R
Br J Haematol; 2016 Aug; 174(4):591-9. PubMed ID: 27161549
[TBL] [Abstract][Full Text] [Related]
38. Pattern of malignant disorders in individuals with Down's syndrome.
Hasle H
Lancet Oncol; 2001 Jul; 2(7):429-36. PubMed ID: 11905737
[TBL] [Abstract][Full Text] [Related]
39. Acute lymphoblastic leukaemia in children with Down syndrome: an updated review.
Maloney KW
Br J Haematol; 2011 Nov; 155(4):420-5. PubMed ID: 21933171
[TBL] [Abstract][Full Text] [Related]
40. Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long-term follow-up.
Secker-Walker LM; Chessells JM; Stewart EL; Swansbury GJ; Richards S; Lawler SD
Br J Haematol; 1989 Jul; 72(3):336-42. PubMed ID: 2765402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
